SCORE

5

NYMX: Nymox Pharmaceutical Corporation is a Sell

AAPL chart by TradingView

The current rating for NYMX is 5, which is 900% below its historic median rating of 50. This indicates higher risk than normal.

The rating is currently showing a lower than normal reading, suggesting risk levels could be higher than normal and additional caution is advised.